project id: TCGA-UCEC; case submitter id: TCGA-DF-A2KS; source center: 23; state: released; a260 a280 ratio: 1.79; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.9; rna integrity number: 8.6; age at index: 69; days to birth: -25313; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; age at diagnosis: 25313; classification of tumor: not reported; days to last follow up: 3318.0; figo stage: Stage IB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 120.0; portion submitter id: TCGA-DF-A2KS-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 3.0; percent necrosis: 20.0; percent neutrophil infiltration: 8.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 75.0; percent tumor nuclei: 95.0;